C M Bidwell & Associates LTD Neurocrine Biosciences Inc Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $83,583 - $104,101	889 New	889 $100,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $38,560 - $45,172	419 New	419 $45,000
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $18,787 - $34,199	-275 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $27,192 - $34,608	275 New	275 $34,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.